GlassScriptPhysician profile
Haley R Shriner
NPI 1740870203
$178.48
in general payments reported to CMS, 2019-2025
7 companies · $66.90 in 2025
The $66.90 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3.06 · 2023: $67.53 · 2024: $40.99 · 2025: $66.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $97.91 | 2023-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Lilly USA, LLC | $20.12 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $19.88 | 2025 | Breztri |
| Exact Sciences Corporation | $14.51 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $13.47 | 2023 | Wegovy |
| Phathom Pharmaceuticals, INC. | $9.53 | 2025 | Voquezna |
| Organon LLC | $3.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Shriner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.